Connecticut 2020 Regular Session

Connecticut House Bill HB05366

Introduced
2/27/20  
Introduced
2/27/20  
Refer
2/27/20  
Report Pass
3/10/20  

Caption

An Act Concerning The Cost Of Prescription Drugs.

Impact

This legislation is expected to significantly affect health care affordability in the state by mandating that health carriers maintain reasonable copayments and deductibles for covered prescription drugs. The cap on total monthly costs could enhance access to essential medications, particularly for low-income individuals or those with chronic conditions who often face substantial prescription expenses. By regulating drug pricing to not exceed 102% of the consumer price index for urban consumers, the bill strives to foster a more predictable pricing environment for outpatients in the state.

Summary

House Bill 05366, titled 'An Act Concerning The Cost Of Prescription Drugs,' aims to address the rising costs associated with prescription medications in the state. The bill sets certain caps on the aggregate monthly out-of-pocket costs that insured individuals have to bear for prescription drugs, limiting this amount to a maximum of $250 per month per insured individual. Furthermore, it establishes guidelines for drug formularies, effectively preventing health carriers from removing necessary medications or altering their cost-sharing tiers without prior notice, thereby ensuring the continued availability of crucial medications for patients.

Contention

Despite its potential benefits, HB 05366 has been the subject of debate. Opponents argue that imposing strict regulations on health insurance carriers could stifle flexibility and adaptability in managing drug costs. Some stakeholders, including pharmaceutical companies and certain insurance organizations, express concerns that the bill's constraints may limit their ability to negotiate prices with suppliers and potentially lead to fewer available medications on the market. Proponents counter that the legislation's intent is to curb excessive price hikes and ensure that the public can afford necessary medications, thus advocating for patient rights over corporate interests.

Companion Bills

No companion bills found.

Previously Filed As

CT SB00008

An Act Concerning Drug Affordability.

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

CT SB00202

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Prescription Drug Control.

CT HB05150

An Act Concerning Cannabis And Hemp Regulation.

CT HB05235

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.

CT SB00292

An Act Concerning The Use Of Pfas In Certain Products.

CT SB00001

An Act Concerning The Health And Safety Of Connecticut Residents.

CT SB00182

An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.

CT SB00134

An Act Concerning The Legislative Commissioners' Recommendations For Minor And Technical Revisions To Statutes Concerning Consumer Protection.

CT SB00449

An Act Concerning A Study Of State Taxation.

Similar Bills

CT HB07192

An Act Implementing Recommendations Of The Bipartisan Drug Task Force.

CT SB00013

An Act Reducing Prescription Drug Prices.

CT HB06870

An Act Addressing Patients' Prescription Drug Costs.

CT SB00008

An Act Concerning Drug Affordability.

CT HB05400

An Act Concerning The Regulation Of Insurance In The State.